Skip to main content

Fentanyl Crisis: A National Security Matter

  • Chapter
  • First Online:
Security by Design

Abstract

The complexity of the current threat landscape associated with terrorism and criminal networks continues to be a top national and global security agenda item. Amongst the global security challenges, synthetic drugs constitute one of the most significant drug problems worldwide (UNODC in Global smart update: fentanyl and its analogous—50 years on, 2017 [54]). Fentanyl and non-pharmaceutical fentanyls (NPFs) have moved beyond being a concern to emerging as a national and global security matter. In 2015, more than 52,000 Americans (144/day) died from drug overdose. As reported by Chester (Fentanyl: the next wave of the opioid crisis, 2017 [9]), 63% of overdoses involved opioids whereby they are having ‘…a considerable impact on public health and public safety in communities across the United States’. In Canada, the Fentanyl-related deaths has markedly increased across British Columbia, Alberta, Ontario and Quebec, ranging from a doubling to 20-fold increase from 2009 to 2014 (CCENDU in Deaths involving fentanyl in Canada, 2009–2014, 2015 [4]). This increasing trend is noted internationally with increasing mortality in Australia (Roxburgh et al. in Drug Alcohol Rev 32:269–275, 2013 [48]) and the Nordic countries (Denmark, Finland, Iceland, Norway, Sweden) (Simonsen et al. in Forensic Sci Int 248:172–180, 2015 [50]). Richmond (An introduction to systems thinking. High Performance Systems, Inc. NH: Hanover, 2001 [46]) argues that ‘The way we think is outdated. As a result, the way we act creates problems, and then we are ill-equipped to address them because of the way we think’. His argument stems from the ‘…fact that we have been applying the same set of non-solutions to the crucial social problems such as drugs, poverty and crime for most of the last fifty years without any positive results’. This chapter examines the national and global fentanyl crisis and introduces a holistic perspective of the problem space that leverages social innovation and macro-social analysis (Boivin in Networks and network analysis for defence and security. Springer, Berlin, 2014 [1]; Masys in Exploring the security landscape—non-traditional security challenges. Springer, Berlin, 2016 [37]) to examine the public health and criminal dimensions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Boivin R (2014) Macrosocial network analysis: the case of transnational drug trafficking. In: Masys AJ (ed) Networks and network analysis for defence and security. Springer, Berlin

    Google Scholar 

  2. Bruinsma G, Bernasco W (2004) Criminal groups and transnational illegal markets. Crime, Law, Soc Change 41:79–94

    Article  Google Scholar 

  3. CFR (2017) The growing U.S. opioid crisis: lessons from around the world. https://www.cfr.org/event/growing-us-opioid-crisis-lessons-around-world

  4. Canadian Community Epidemiology Network on Drug Use (CCENDU) (2015) Deaths involving fentanyl in Canada, 2009–2014. Ottawa, Ontario

    Google Scholar 

  5. Canadian Pharmacists Association (CPhA) (2017) Environmental scan: access to naloxone across Canada. Ottawa, Ontario

    Google Scholar 

  6. Carney A (2017) The current national opioid crisis: conceptualizing a plan of action. http://inquirepublication.com/the-current-national-opioid-crisis-conceptualizing-a-plan-of-action/

  7. Centers for Disease Control and Prevention (CDC) (2017a) Fentanyl: preventing occupational exposure to emergency responders. https://www.cdc.gov/niosh/topics/fentanyl/risk.html

  8. Centers for Disease Control and Prevention (CDC) (2017b) Opioid data analysis. https://www.cdc.gov/drugoverdose/data/analysis.html

  9. Chester KL (2017) Fentanyl: the next wave of the opioid crisis. Subcommittee on oversight and investigations committee on energy and commerce United States house of representatives. http://docs.house.gov/meetings/IF/IF02/20170321/105739/HHRG-115-IF02-Wstate-ChesterK-20170321.pdf

  10. Cobaugh DJ, Gainor C, Gaston CL, Kwong TC et al (2014) The opioid abuse and misuse epidemic: implications for pharmacists and health systems. Am J Health Syst Pharm 71:1539–1554

    Article  Google Scholar 

  11. DODAF (2015) DODAF V 2.0. Volume II: Architectural data and models. Available at: http://dodcio.defense.gov/Portals/0/Documents/DODAF2/DoDAF%20v2.02%20Chg%201%20Vol%20II%20Final%202015-01-19.pdf [accessed 11 Oct 2015]

  12. Drewes AM, Jensen RD, Nielsen LM, Droney J et al (2013) Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br J Clin Pharmacol 75:60–78

    Article  Google Scholar 

  13. Duijn PAC, Sloot PMA (2015) From data to disruption. Digit Invest 15:39–45

    Article  Google Scholar 

  14. Duijn PAC, Klerks PPHM (2014) Social network analysis applied to criminal networks: recent developments in Dutch law enforcement. In Masys AJ (ed) Networks and network analysis for defence and security. Springer

    Google Scholar 

  15. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2016) Preventing OPIOID overdose deaths with take-home Naloxone. http://www.emcdda.europa.eu/system/files/attachments/2092/News%20release_1_EN_2016_Naloxone_Final.pdf

  16. Farrell M (2014) Drug legalisation. BMJ 349:g5233

    Google Scholar 

  17. Feng Y, He X, Yang Y, Chao D et al (2012) Current research on opioid receptor function. Curr Drug Targets 13:230–246

    Article  Google Scholar 

  18. Fischer B, Russell C, Murphy Y, Kurdyak P (2015) Prescription opioids, abuse and public health in Canada: is fentanyl the new centre of the opioid crisis? Pharmacoepidemiol Drug Saf 24:1334–1336

    Article  Google Scholar 

  19. Florence CS, Zhou C, Luo F, Xu L (2016) The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Med Care 54:901–906

    Article  Google Scholar 

  20. Frank RG, Pollack HA (2017) Addressing the fentanyl threat to public health. NEJM 376(7):605–607

    Article  Google Scholar 

  21. Friesen KJ, Woelk C, Bugden S (2016) Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches. Can Med Assoc J 188:648–653

    Article  Google Scholar 

  22. Gladden RM, Martinez P, Seth P (2016) Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths—27 states, 2013–2014. Centers Dis Control Prev MMWR 65(33):837–843

    Google Scholar 

  23. Goldin I, Mariathasan M (2014) The butterfly defect: how globalization creates systemic risks and what to do about it. Princeton University Press, Princeton, NJ

    Google Scholar 

  24. Halliday JEB, Hampson K, Hanley N, Lembo T, Sharp JP, Haydon DT, Cleaveland S (2017) Driving improvements in emerging disease surveillance through locally relevant capacity strengthening. Science 357(6347):146–148

    Article  Google Scholar 

  25. International Narcotics Control Board (2016) Narcotic Drugs 2016. https://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2016/Narcotic_Drugs_Publication_2016.pdf

  26. Janssen Inc. (2017) Product monograph: Duragesic. Markham, Ontario

    Google Scholar 

  27. Kanjhan R (1995) Opioids and pain. Clin Exp Pharmacol Physiol 22:397–403

    Article  Google Scholar 

  28. Kaundert M, Masys AJ (2018) Mass migration, humanitarian assistance and crisis management: embracing social innovation and organizational learning. In: Masys AJ (ed) Security by design. Springer Publishing

    Google Scholar 

  29. Kerensky T, Walley AY (2017) Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know. Addict Sci Clin Pract 12:4

    Article  Google Scholar 

  30. Levi M, Maguire M (2004) Reducing and preventing organised crime: an evidence-based critique. Crime, Law Soc Change 41: 397–469

    Google Scholar 

  31. Lotsch J, Walter C, Parnham MJ, Oertel BG et al (2013) Pharmacokinetics of non-intravenous formulations of fentanyl. Clin Pharmacokinet 53:23–36

    Article  Google Scholar 

  32. Marquardt KA, Tharratt RS, Musallam NA (1995) Fentanyl remaining in a transdermal system following three days of continuous use. Ann Pharmacother 29:969–971

    Article  Google Scholar 

  33. Masys AJ (ed) (2015) Applications of systems thinking and soft operations research in managing complexity. Springer Publishing

    Google Scholar 

  34. Masys AJ (2016) Disrupting terrorist and criminal networks: crime script analysis through DODAF applications. In: Masys AJ (ed) Exploring the security landscape—non-traditional security challenges. Springer, Berlin

    Google Scholar 

  35. Meda Pharmaceuticals Inc. (2012) Product monograph: Onsolis. Solna, Sweden

    Google Scholar 

  36. Moore M, Westley F (2011) Surmountable chasms: networks and social innovation for resilient systems. Ecology and Society 16(1):5. [online] URL: http://www.ecologyandsociety.org/vol16/iss1/art5/

  37. Mounteney J, Giraudon I, Denissov G, Griffiths P (2015) Fentanyls: are we missing the signs? Highly potent and on the rise in Europe. Int J Drug Policy 26:626–631

    Article  Google Scholar 

  38. Murray R, Caulier-Grice J, Mulgan G (2010) The open book of social innovation. Nesta

    Google Scholar 

  39. Nicholls A, Simon J, Gabriel M (2015) Introduction: dimensions of social innovation. In: Nicholls A, Simon J, Gabriel M (eds) New frontiers in social innovation research. Palgrave Macmillan

    Google Scholar 

  40. O’Connor S (2017) Fentanyl: China’s deadly export to the United States. U.S.-China economic and security review commission. https://www.uscc.gov/sites/default/files/Research/USCC%20Staff%20Report_Fentanyl-China%E2%80%99s%20Deadly%20Export%20to%20the%20United%20States020117.pdf

  41. Paladin Labs Inc. (2017) Product monograph: abstral. St-Laurent, Quebec

    Google Scholar 

  42. Patton MQ (2011) Developmental evaluation: applying complexity concepts to enhance innovation and use. Guilford Press, New York

    Google Scholar 

  43. Pereira J, Lawlor P, Vigano A, Dorgan M et al (2001) Equianalgesic dose ratios for opioids: a critical review and proposals for long-term dosing. J Pain Symptom Manage 22:672–687

    Article  Google Scholar 

  44. Phills JA, Deiglmeier K, Miller DT (2008) Rediscovering social innovation. Stanford Soc Innov Rev Fall 2008: 34–43

    Google Scholar 

  45. Prekupec MP, Mansky PA, Baumann MH (2017) Misuse of novel synthetic opioids: a deadly new trend. J Addict Med 11(4):256–265

    Article  Google Scholar 

  46. Richmond B (2001) An introduction to systems thinking (iThink software). High Performance Systems, Inc. NH: Hanover

    Google Scholar 

  47. Roberts N, Everton SF (2011) Strategies for combatting dark networks. J Soc Struct 12(2). http://www.cmu.edu/joss/content/articles/volume12//RobertsEverton.pdf

  48. Roxburgh A, Burns L, Drummer OH, Pilgrim J et al (2013) Trends in fentanyl prescriptions and fentanyl-related mortality in Australia. Drug Alcohol Rev 32:269–275

    Article  Google Scholar 

  49. Sandoz Canada Inc. (2013) Product Monograph: Fentanyl Citrate Injection. Boucherville, Quebec

    Google Scholar 

  50. Simonsen KW, Edvardsen HM, Thelander G, Ojanpera I et al (2015) Fatal poisoning in drugs addicts in the Nordic countries in 2012. Forensic Sci Int 248:172–180

    Article  Google Scholar 

  51. Stanley TH (2014) The fentanyl story. J Pain 15:1215–1226

    Article  Google Scholar 

  52. Suzuki J, El-Haddad S (2017) A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend 171(2017):107–116

    Article  Google Scholar 

  53. Trescot AM, Datta S, Lee M, Hansen H (2008) Opioid pharmacology. Pain Physician 11:S133–S153

    Google Scholar 

  54. UNODC (2017) Global smart update: fentanyl and its analogous—50 years on. https://www.unodc.org/documents/scientific/Global_SMART_Update_17_web.pdf

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anthony J. Masys .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tsang, C., Masys, A.J. (2018). Fentanyl Crisis: A National Security Matter. In: Masys, A. (eds) Security by Design. Advanced Sciences and Technologies for Security Applications. Springer, Cham. https://doi.org/10.1007/978-3-319-78021-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-78021-4_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-78020-7

  • Online ISBN: 978-3-319-78021-4

  • eBook Packages: Law and CriminologyLaw and Criminology (R0)

Publish with us

Policies and ethics